Advances in the preclinical characterization of the antimicrobial peptide AS-48.

Cebrián, Rubén; Martínez-García, Marta; Fernández, Matilde; García, Federico; Martínez-Bueno, Manuel; Valdivia, Eva; Kuipers, Oscar P; Montalbán-López, Manuel; Maqueda, Mercedes

Cebrián, Rubén; Martínez-García, Marta; Fernández, Matilde; García, Federico; Martínez-Bueno, Manuel; Valdivia, Eva; Kuipers, Oscar P; Montalbán-López, Manuel; Maqueda, Mercedes.

Afiliação

Cebrián R; Department of Clinical Microbiology, Instituto de Investigación Biosanitaria Ibs.GRANADA, University Hospital San Cecilio, Granada, Spain.
Martínez-García M; Department of Molecular Genetics, University of Groningen, Groningen, Netherlands.
Fernández M; Department of Microbiology, University of Granada, Granada, Spain.
García F; Department of Clinical Microbiology, Instituto de Investigación Biosanitaria Ibs.GRANADA, University Hospital San Cecilio, Granada, Spain.
Martínez-Bueno M; Biomedicinal Research Network Center, Infectious Diseases (CIBERINFEC), Madrid, Spain.
Valdivia E; Department of Microbiology, University of Granada, Granada, Spain.
Kuipers OP; Department of Microbiology, University of Granada, Granada, Spain.
Montalbán-López M; Department of Molecular Genetics, University of Groningen, Groningen, Netherlands.
Maqueda M; Department of Microbiology, University of Granada, Granada, Spain.

Front Microbiol ; 14: 1110360, 2023.

Article em En | MEDLINE | ID: mdl-36819031

Palavras-chave

AS-48; antimicrobial peptide; antimicrobial resistance; bacteriocin; enterocin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Microbiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google